27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Adam Feuerstein was recently a guest on #PreMarket Prep, a daily trading idea radio show hosted by Joel Elconin and Dennis Dick..
TheStreet Senior Columnist Adam Feuerstein discussed Bristol-Myers Squibb Co (NYSE: BMY) on the show.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Feuerstein pointed out that the company announced Friday that it stopped a lung cancer drug trial early.
The news was positive because, according to Feuerstein, the drug was working so well and had “overwhelming efficacy.”
“That’s just more good news for Bristol-Myers,” Feuerstein said, as it would fuel further investor interest in cancer immunotherapy stocks.
Bristol-Myers recently traded at $65.49, up 2.84 percent.
Check out the full interview below. Feuerstein comes in at about the 1-hour mark:
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.